SEC Form 5 · accession 0001185185-17-001516
INVO Bioscience, Inc. · IVOB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Kathleen t Karloff
Officer — CEO/Chairman · Director
Period of report
Dec 31, 2016
Accepted (ET)
Jul 3, 2017 · 3:21 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001417926
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| INVO Bioscience Common Stock Restricted | Mar 4, 2016 | D | 1,000,000 | $0.30 | D | 11,160,000 | D | |
| INVO Bioscience Common Stock Restricted | May 26, 2016 | A | 1,000,000 | $0.36 | D | 12,160,000 | D |
Table II — derivative securities
No Table II lines on this filing.